CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Consolidated Statements Of Operations
Revenue
Operating expense
Research and development	79,080	111,822
General and administrative	303,023	669,070
Total operating expenses	382,103	780,892
Loss from operations	(382,103)	(780,892)
Other income (expense)
Interest income	258
Interest expense	(15,350)
Accretion of debt discount	(174,629)
Total other income (expense)	(189,721)
Net loss	$ (571,824)	$ (780,892)
Basic and Diluted Loss per Common Share	$ (0.01)	$ (0.01)
Weighted average number of common shares outstanding - basic and diluted	71,708,814	69,167,505